← All stocks

Alkermes plc.

ALKS Mostly scheduled
CIK 0001520262 #1047 in the set updated 17 Sep 2026
Bought (120 mo)
$1.42M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$153.30M
$3.67M on a plan · $144.35M straight out of an exercise
Sold at will
$5.28M
13 of 262 sales
Net
−$151.88M
−$3.86M against sales at will

By person

30 insiders · 295 transactions
52.8×

Richard F. Pops holds 52.8 times base salary in stock. $66.15M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard F. Pops last reported holding, valued at $48.01, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
POPS RICHARD F
Director and CEO, Alkermes plc
$62.69M (47) scheduled
−$62.69M
1,377,740
0.8212%
$66.15M
+130.2%
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$24.75M (30) scheduled
−$24.75M
65,389
0.0390%
$3.14M
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
$14.45M (30) scheduled
−$14.45M
281,730
0.1679%
$13.53M
+84.1%
Cooke Shane
Director
$12.24M (24) scheduled
−$12.24M
106,679
0.0636%
$5.12M
+76.8%
FRATES JAMES M
SVP, Alks Inc; CFO ALKS
$7.08M (11) scheduled
−$7.08M
91,828
0.0547%
$4.41M
+304.2%
Ehrich Elliot
EVP, R&D & CMO, Alkermes, Inc.
$4.53M (15) scheduled
−$4.53M
57,056
0.0340%
$2.74M
+25.9%
BIBERSTEIN KATHRYN L
EVP/CAO/CCO/CRO Alks Inc;
$3.20M (11) scheduled
−$3.20M
40,200
0.0240%
$1.93M
Brown Iain Michael
SVP, Chief Financial Officer
$2.58M (5) scheduled
−$2.58M
148,196
0.0883%
$7.11M
+779.8%
Jackson Blair Curtis
President & CEO, Alkermes plc
$2.25M (2) scheduled
−$2.25M
241,308
0.1438%
$11.59M
+312.3%
snyderman nancy lynn MD
Director
$10.00K (1)
$2.24M (1) scheduled
−$2.23M
15,395
0.0092%
$739.11K
Nichols Christian Todd
SVP, Chief Commercial Officer
$2.20M (9) scheduled
−$2.20M
102,193
0.0609%
$4.91M
MITCHELL PAUL J
Director
$2.05M (30) scheduled
−$2.05M
18,174
0.0108%
$872.53K
+127.2%
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
$2.01M (15) scheduled
−$2.01M
223,422
0.1332%
$10.73M
+993.4%
Stejbach Mark
SVP/Chief Comm Off, Alks Inc
$1.97M (6) scheduled
−$1.97M
51,065
0.0304%
$2.45M
+91.6%
BREYER ROBERT A
Director
$1.68M (3)
−$1.68M
10,330
0.0062%
$495.94K
−70.6%
Pugh Gordon G
SVP, COO & CRO, Alkermes, Inc.
$1.24M (2) scheduled
−$1.24M
59,324
0.0354%
$2.85M
−9.5%
ANSTICE DAVID W
Director
$1.22M (6) scheduled
−$1.22M
84,905
0.0506%
$4.08M
+466.0%
Parisi Samuel Joseph
VP, Finance (Interim PAO)
$1.21M (6) scheduled
−$1.21M
7,717
0.0046%
$370.49K
+97.9%
DIXON WENDY L
Director
$1.13M (2) scheduled
−$1.13M
53,124
0.0317%
$2.55M
+3,220%
Wysenski Nancy
Director
$278.71K (3)
$1.29M (1) scheduled
−$1.01M
31,598
0.0188%
$1.52M
BLOOM FLOYD E
Director
$879.02K (1)
−$879.02K
127,923
0.0763%
$6.14M
0.0%
Daglio David Angelo Jr.
Director
$815.73K (1)
+$815.73K
107,780
0.0642%
$5.17M
+139.5%
LAURENCIN CATO T
Director
$343.61K (4) scheduled
−$343.61K
33,769
0.0201%
$1.62M
MCKEON BRIAN P
Director
$264.27K (1)
+$264.27K
48,536
0.0289%
$2.33M
Wright Christopher I
Director
$90.20K (1) scheduled
−$90.20K
25,680
0.0153%
$1.23M
Alva Emily Peterson
Director
$49.86K (1)
+$49.86K
27,302
0.0163%
$1.31M
Wilson Frank Anders
Director
35,751
0.0213%
$1.72M
GAYNOR RICHARD
Director
35,751
0.0213%
$1.72M
Lurker Nancy
Director
18,222
0.0109%
$874.84K
Robinson James A. Jr.
President & COO,Alkermes, Inc.
4,412
0.0026%
$211.82K
Insider
Date
Role
Action
Shares
Price
Amount
Hopkinson Craig C.
1 Sep 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$46.99
$422.87K
Hopkinson Craig C.
3 Aug 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$48.58
$437.22K
snyderman nancy lynn MD
3 Aug 2026
Director
Sold after exercise
44,472
$50.35
$2.24M
Hopkinson Craig C.
1 Jul 2026
EVP R&D, Chief Medical Officer
Sold after exercise
700
$52.13
$36.49K
Hopkinson Craig C.
1 Jul 2026
EVP R&D, Chief Medical Officer
Sold after exercise
8,300
$51.46
$427.13K
Hopkinson Craig C.
1 Jun 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$41.67
$375.04K
Parisi Samuel Joseph
29 May 2026
VP, Finance (Interim PAO)
Sold after exercise
16,217
$42.36
$687.01K
Hopkinson Craig C.
1 May 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$33.40
$300.56K
Hopkinson Craig C.
1 Apr 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$35.51
$319.60K
Hopkinson Craig C.
2 Mar 2026
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$29.72
$267.49K
Cooke Shane
2 Feb 2026
Director
Sold after exercise
32,113
$34.78
$1.12M
Cooke Shane
2 Feb 2026
Director
Sold after exercise
29,087
$34.34
$998.80K
Hopkinson Craig C.
2 Feb 2026
EVP R&D, Chief Medical Officer
Sold after exercise
4,000
$33.54
$134.16K
Hopkinson Craig C.
2 Feb 2026
EVP R&D, Chief Medical Officer
Sold after exercise
5,000
$34.24
$171.22K
Hopkinson Craig C.
8 Jan 2026
EVP R&D, Chief Medical Officer
Sold after exercise
5,000
$30.00
$150.01K
Hopkinson Craig C.
3 Dec 2025
EVP R&D, Chief Medical Officer
Sold after exercise
3,748
$30.00
$112.45K
Hopkinson Craig C.
3 Nov 2025
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$30.38
$273.44K
Hopkinson Craig C.
15 Oct 2025
EVP R&D, Chief Medical Officer
Sold after exercise
9,000
$31.53
$283.78K
Hopkinson Craig C.
13 Feb 2025
EVP R&D, Chief Medical Officer
Sold after exercise
108,833
$36.02
$3.92M
Hopkinson Craig C.
13 Feb 2025
EVP R&D, Chief Medical Officer
Sold after exercise
35,586
$34.02
$1.21M
Hopkinson Craig C.
12 Feb 2025
EVP R&D, Chief Medical Officer
Sold after exercise
33,108
$33.27
$1.10M
Hopkinson Craig C.
12 Feb 2025
EVP R&D, Chief Medical Officer
Sold after exercise
171,813
$32.69
$5.62M
Hopkinson Craig C.
30 Jan 2025
EVP R&D, Chief Medical Officer
Sold after exercise
100,918
$32.05
$3.23M
LAURENCIN CATO T
9 Dec 2024
Director
Sold after exercise
2,691
$31.85
$85.71K
Hopkinson Craig C.
9 Dec 2024
EVP R&D, Chief Medical Officer
Sold after exercise
61,151
$32.07
$1.96M
Hopkinson Craig C.
11 Nov 2024
EVP R&D, Chief Medical Officer
Sold after exercise
58,996
$30.08
$1.77M
LAURENCIN CATO T
15 Feb 2024
Director
Sold after exercise
2,690
$31.85
$85.68K
LAURENCIN CATO T
8 Jun 2023
Director
Sold after exercise
2,638
$31.85
$84.02K
LAURENCIN CATO T
7 Jun 2023
Director
Sold after exercise
2,800
$31.50
$88.20K
Nichols Christian Todd
30 May 2023
SVP, Chief Commercial Officer
Sold after exercise
27,134
$28.93
$784.86K
Wysenski Nancy
9 May 2023
Director
Sold after exercise
41,250
$31.24
$1.29M
LANDINE MICHAEL J
17 May 2022
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
50,000
$29.15
$1.46M
LANDINE MICHAEL J
10 May 2022
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$27.22
$680.38K
POPS RICHARD F
6 May 2022
Director and CEO, Alkermes plc
Sold after exercise
93,747
$27.85
$2.61M
POPS RICHARD F
5 May 2022
Director and CEO, Alkermes plc
Sold after exercise
32,288
$28.59
$923.23K
POPS RICHARD F
5 May 2022
Director and CEO, Alkermes plc
Sold after exercise
221,222
$27.95
$6.18M
LANDINE MICHAEL J
3 May 2022
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$28.62
$715.42K
Cooke Shane
2 May 2022
Director
Sold after exercise
10,000
$29.23
$292.33K
Cooke Shane
25 Apr 2022
Director
Sold after exercise
10,000
$27.88
$278.85K
Jackson Blair Curtis
20 Apr 2022
EVP, Chief Operating Officer
Sold after exercise
49,999
$29.61
$1.48M
Cooke Shane
18 Apr 2022
Director
Sold after exercise
10,000
$28.88
$288.75K
Cooke Shane
11 Apr 2022
Director
Sold after exercise
10,000
$29.26
$292.60K
Cooke Shane
4 Apr 2022
Director
Sold after exercise
10,000
$28.18
$281.85K
Brown Iain Michael
19 Aug 2021
SVP, Chief Financial Officer
Sold after exercise
40,000
$29.99
$1.20M
Gaffin David Joseph
29 Jul 2021
SVP, CLO, Alkermes, Inc.
Sold after exercise
14,000
$26.00
$364.00K
ANSTICE DAVID W
1 Jul 2021
Director
Sold after exercise
20,000
$24.58
$491.50K
DIXON WENDY L
10 Jun 2021
Director
Sold after exercise
25,000
$25.00
$625.00K
Gaffin David Joseph
10 Jun 2021
SVP, CLO, Alkermes, Inc.
Sold after exercise
13,500
$25.00
$337.50K
ANSTICE DAVID W
7 Jun 2021
Director
Sold after exercise
5,000
$24.00
$120.00K
Gaffin David Joseph
7 Jun 2021
SVP, CLO, Alkermes, Inc.
Sold after exercise
13,500
$24.00
$324.00K
POPS RICHARD F
18 May 2021
Director and CEO, Alkermes plc
Sold after exercise
150,000
$21.90
$3.29M
LANDINE MICHAEL J
17 May 2021
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
50,000
$22.09
$1.10M
Gaffin David Joseph
14 May 2021
SVP, CLO, Alkermes, Inc.
Sold after exercise
2,250
$22.23
$50.02K
LANDINE MICHAEL J
13 May 2021
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$22.39
$559.70K
POPS RICHARD F
11 May 2021
Director and CEO, Alkermes plc
Sold after exercise
60,297
$22.30
$1.34M
POPS RICHARD F
11 May 2021
Director and CEO, Alkermes plc
Sold after exercise
89,703
$21.95
$1.97M
LANDINE MICHAEL J
7 May 2021
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
19,477
$22.10
$430.52K
POPS RICHARD F
6 May 2021
Director and CEO, Alkermes plc
Sold after exercise
100,000
$21.79
$2.18M
Jackson Blair Curtis
3 May 2021
EVP, Chief Operating Officer
Sold after exercise
34,503
$22.18
$765.16K
Brown Iain Michael
19 Apr 2021
SVP, Chief Financial Officer
Sold after exercise
34,792
$20.00
$695.76K
DIXON WENDY L
19 Apr 2021
Director
Sold after exercise
25,000
$20.00
$500.12K
Brown Iain Michael
16 Apr 2021
SVP, Chief Financial Officer
Sold after exercise
208
$19.99
$4.16K
MITCHELL PAUL J
1 Oct 2020
Director
Sold after exercise indirect
20,000
$16.61
$332.26K
ANSTICE DAVID W
28 Sep 2020
Director
Sold after exercise
17,832
$16.79
$299.31K
POPS RICHARD F
14 May 2020
Director and CEO, Alkermes plc
Sold after exercise
75,000
$15.00
$1.13M
Brown Iain Michael
13 May 2020
SVP Finance & CAO, Alks Inc.
Sold after exercise
6,250
$15.39
$96.19K
LANDINE MICHAEL J
12 May 2020
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
18,000
$15.75
$283.47K
POPS RICHARD F
7 May 2020
Director and CEO, Alkermes plc
Sold after exercise
50,000
$14.63
$731.27K
LANDINE MICHAEL J
5 May 2020
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$14.06
$351.43K
POPS RICHARD F
2 Apr 2020
Director and CEO, Alkermes plc
Sold after exercise
50,000
$13.79
$689.50K
POPS RICHARD F
26 Mar 2020
Director and CEO, Alkermes plc
Sold after exercise
75,000
$14.36
$1.08M
LANDINE MICHAEL J
24 Mar 2020
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$13.91
$347.72K
POPS RICHARD F
19 Mar 2020
Director and CEO, Alkermes plc
Sold after exercise
15,986
$15.04
$240.39K
POPS RICHARD F
19 Mar 2020
Director and CEO, Alkermes plc
Sold after exercise
48,668
$14.51
$706.17K
POPS RICHARD F
19 Mar 2020
Director and CEO, Alkermes plc
Sold after exercise
10,346
$13.42
$138.87K
LANDINE MICHAEL J
17 Mar 2020
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
2,700
$14.26
$38.50K
LANDINE MICHAEL J
17 Mar 2020
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
22,300
$13.45
$300.00K
POPS RICHARD F
14 Nov 2019
Director and CEO, Alkermes plc
Sold after exercise
100,000
$19.50
$1.95M
LANDINE MICHAEL J
13 Nov 2019
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
20,000
$19.70
$394.06K
POPS RICHARD F
8 Nov 2019
Director and CEO, Alkermes plc
Sold after exercise
30,205
$19.73
$595.83K
POPS RICHARD F
7 Nov 2019
Director and CEO, Alkermes plc
Sold after exercise
69,795
$19.81
$1.38M
LANDINE MICHAEL J
6 Nov 2019
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
20,000
$19.76
$395.12K
POPS RICHARD F
19 Sep 2019
Director and CEO, Alkermes plc
Sold after exercise
100,000
$21.54
$2.15M
POPS RICHARD F
12 Sep 2019
Director and CEO, Alkermes plc
Sold after exercise
100,000
$22.68
$2.27M
POPS RICHARD F
5 Sep 2019
Director and CEO, Alkermes plc
Sold after exercise
100,000
$20.18
$2.02M
POPS RICHARD F
23 May 2019
Director and CEO, Alkermes plc
Sold after exercise
50,000
$24.22
$1.21M
LANDINE MICHAEL J
22 May 2019
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
20,000
$24.93
$498.53K
POPS RICHARD F
16 May 2019
Director and CEO, Alkermes plc
Sold after exercise
60,000
$25.42
$1.53M
Gaffin David Joseph
9 May 2019
SVP, CLO, Alkermes, Inc.
Sold after exercise
3,120
$27.00
$84.24K
Gaffin David Joseph
9 May 2019
SVP, CLO, Alkermes, Inc.
Sold after exercise
2,253
$26.75
$60.26K
MITCHELL PAUL J
1 Apr 2019
Director
Sold after exercise indirect
1,000
$36.64
$36.64K
LANDINE MICHAEL J
14 Mar 2019
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
25,000
$33.05
$826.37K
POPS RICHARD F
13 Mar 2019
Director and CEO, Alkermes plc
Sold after exercise
15,829
$33.51
$530.49K
POPS RICHARD F
12 Mar 2019
Director and CEO, Alkermes plc
Sold after exercise
44,171
$33.24
$1.47M
LANDINE MICHAEL J
7 Mar 2019
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
20,000
$32.07
$641.36K
POPS RICHARD F
5 Mar 2019
Director and CEO, Alkermes plc
Sold after exercise
50,000
$33.63
$1.68M
MITCHELL PAUL J
1 Mar 2019
Director
Sold after exercise indirect
1,000
$33.48
$33.48K
MITCHELL PAUL J
1 Feb 2019
Director
Sold after exercise indirect
1,000
$32.73
$32.73K
MITCHELL PAUL J
4 Jan 2019
Director
Sold after exercise indirect
1,000
$30.00
$30.00K
ANSTICE DAVID W
12 Dec 2018
Director
Sold after exercise
5,000
$35.56
$177.79K
ANSTICE DAVID W
12 Dec 2018
Director
Sold after exercise
235
$35.92
$8.44K
ANSTICE DAVID W
12 Dec 2018
Director
Sold after exercise
3,552
$35.61
$126.48K
MITCHELL PAUL J
3 Dec 2018
Director
Sold after exercise indirect
1,000
$36.45
$36.45K
MITCHELL PAUL J
2 Nov 2018
Director
Sold after exercise indirect
1,000
$37.51
$37.51K
MITCHELL PAUL J
1 Oct 2018
Director
Sold after exercise indirect
1,000
$42.42
$42.42K
MITCHELL PAUL J
4 Sep 2018
Director
Sold after exercise indirect
1,000
$44.58
$44.58K
MITCHELL PAUL J
1 Aug 2018
Director
Sold after exercise indirect
1,000
$43.68
$43.68K
MITCHELL PAUL J
3 Jul 2018
Director
Sold after exercise indirect
1,000
$41.86
$41.86K
MITCHELL PAUL J
1 Jun 2018
Director
Sold after exercise indirect
1,000
$47.34
$47.34K
LANDINE MICHAEL J
24 May 2018
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
20,000
$45.22
$904.42K
POPS RICHARD F
22 May 2018
Director and CEO, Alkermes plc
Sold after exercise
3,682
$46.03
$169.49K
POPS RICHARD F
22 May 2018
Director and CEO, Alkermes plc
Sold after exercise
16,318
$45.33
$739.67K
LANDINE MICHAEL J
17 May 2018
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
3,100
$47.15
$146.15K
LANDINE MICHAEL J
17 May 2018
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
16,900
$45.96
$776.69K
POPS RICHARD F
15 May 2018
Director and CEO, Alkermes plc
Sold after exercise
50,000
$46.38
$2.32M
POPS RICHARD F
8 May 2018
Director and CEO, Alkermes plc
Sold after exercise
7,360
$44.55
$327.86K
POPS RICHARD F
8 May 2018
Director and CEO, Alkermes plc
Sold after exercise
42,640
$44.28
$1.89M
POPS RICHARD F
1 May 2018
Director and CEO, Alkermes plc
Sold after exercise
900
$44.66
$40.20K
POPS RICHARD F
1 May 2018
Director and CEO, Alkermes plc
Sold after exercise
49,100
$44.01
$2.16M
MITCHELL PAUL J
1 May 2018
Director
Sold after exercise indirect
1,000
$44.32
$44.32K
MITCHELL PAUL J
2 Apr 2018
Director
Sold after exercise indirect
1,000
$46.75
$46.75K
MITCHELL PAUL J
1 Mar 2018
Director
Sold after exercise
1,000
$57.04
$57.04K
Stejbach Mark
16 Feb 2018
SVP/Chief Comm Off, Alks Inc
Sold after exercise
10,880
$70.50
$767.09K
Cooke Shane
2 Feb 2018
President, Alkermes plc
Sold after exercise
19,504
$61.03
$1.19M
Cooke Shane
2 Feb 2018
President, Alkermes plc
Sold after exercise
53,289
$60.38
$3.22M
MITCHELL PAUL J
1 Feb 2018
Director
Sold after exercise
1,000
$56.77
$56.77K
Cooke Shane
29 Jan 2018
President, Alkermes plc
Sold after exercise
3,300
$60.00
$198.00K
Cooke Shane
26 Jan 2018
President, Alkermes plc
Sold after exercise
1,700
$60.02
$102.03K
Cooke Shane
11 Jan 2018
President, Alkermes plc
Sold after exercise
6,207
$60.22
$373.81K
MITCHELL PAUL J
2 Jan 2018
Director
Sold after exercise
1,000
$54.99
$54.99K
MITCHELL PAUL J
1 Dec 2017
Director
Sold after exercise
1,000
$51.98
$51.98K
FRATES JAMES M
29 Nov 2017
SVP, Alks Inc; CFO ALKS
Sold after exercise
400
$51.25
$20.50K
FRATES JAMES M
29 Nov 2017
SVP, Alks Inc; CFO ALKS
Sold after exercise
20,532
$50.49
$1.04M
FRATES JAMES M
8 Nov 2017
SVP, Alks Inc; CFO ALKS
Sold after exercise
20,932
$47.58
$996.01K
POPS RICHARD F
2 Nov 2017
Director and CEO, Alkermes plc
Sold after exercise
50,000
$48.87
$2.44M
LANDINE MICHAEL J
1 Nov 2017
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
15,000
$48.71
$730.69K
MITCHELL PAUL J
1 Nov 2017
Director
Sold after exercise
1,000
$49.16
$49.16K
MITCHELL PAUL J
2 Oct 2017
Director
Sold after exercise
1,500
$50.64
$75.96K
BIBERSTEIN KATHRYN L
11 Sep 2017
EVP/CAO/CCO Alks Inc; Sec ALKS
Sold after exercise
2,499
$51.77
$129.38K
BIBERSTEIN KATHRYN L
11 Sep 2017
EVP/CAO/CCO Alks Inc; Sec ALKS
Sold after exercise
11,067
$51.18
$566.44K
MITCHELL PAUL J
1 Sep 2017
Director
Sold after exercise
1,500
$50.77
$76.16K
MITCHELL PAUL J
1 Aug 2017
Director
Sold after exercise
1,500
$54.91
$82.37K
MITCHELL PAUL J
3 Jul 2017
Director
Sold after exercise
1,500
$58.11
$87.17K
Cooke Shane
8 Jun 2017
President, Alkermes plc
Sold after exercise
10,000
$60.33
$603.33K
Stejbach Mark
8 Jun 2017
SVP/Chief Comm Off, Alks Inc
Sold after exercise
10,000
$60.34
$603.35K
MITCHELL PAUL J
1 Jun 2017
Director
Sold after exercise
1,500
$57.49
$86.24K
POPS RICHARD F
24 May 2017
Director and CEO, Alkermes plc
Sold after exercise
25,000
$57.42
$1.44M
LANDINE MICHAEL J
18 May 2017
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
1,300
$57.81
$75.16K
LANDINE MICHAEL J
18 May 2017
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
8,700
$57.14
$497.10K
POPS RICHARD F
17 May 2017
Director and CEO, Alkermes plc
Sold after exercise
5,939
$59.06
$350.74K
POPS RICHARD F
17 May 2017
Director and CEO, Alkermes plc
Sold after exercise
32,406
$58.37
$1.89M
POPS RICHARD F
17 May 2017
Director and CEO, Alkermes plc
Sold after exercise
11,655
$57.23
$667.06K
LANDINE MICHAEL J
11 May 2017
SVP, Corp Dev., Alkermes, Inc.
Sold after exercise
10,000
$57.01
$570.08K
POPS RICHARD F
10 May 2017
Director and CEO, Alkermes plc
Sold after exercise
7,841
$57.67
$452.16K
POPS RICHARD F
10 May 2017
Director and CEO, Alkermes plc
Sold after exercise
17,159
$57.12
$980.09K
Cooke Shane
4 May 2017
President, Alkermes plc
Sold after exercise
6,500
$60.05
$390.33K
MITCHELL PAUL J
1 May 2017
Director
Sold after exercise
1,500
$58.74
$88.11K
Cooke Shane
1 May 2017
President, Alkermes plc
Sold after exercise
3,500
$60.05
$210.16K
Ehrich Elliot
17 Apr 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
10,000
$56.60
$565.99K
MITCHELL PAUL J
3 Apr 2017
Director
Sold after exercise
1,500
$58.31
$87.47K
BIBERSTEIN KATHRYN L
3 Apr 2017
EVP/CAO/CCO Alks Inc; Sec ALKS
Sold after exercise
300
$59.13
$17.74K
BIBERSTEIN KATHRYN L
3 Apr 2017
EVP/CAO/CCO Alks Inc; Sec ALKS
Sold after exercise
3,763
$58.35
$219.59K
BIBERSTEIN KATHRYN L
3 Apr 2017
EVP/CAO/CCO Alks Inc; Sec ALKS
Sold after exercise
10,937
$57.41
$627.91K
Cooke Shane
29 Mar 2017
President, Alkermes plc
Sold after exercise
2,070
$60.00
$124.20K
Cooke Shane
23 Mar 2017
President, Alkermes plc
Sold after exercise
6,030
$60.01
$361.86K
Cooke Shane
21 Mar 2017
President, Alkermes plc
Sold after exercise
1,600
$60.10
$96.16K
Cooke Shane
20 Mar 2017
President, Alkermes plc
Sold after exercise
300
$60.00
$18.00K
Ehrich Elliot
15 Mar 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
6,900
$57.00
$393.32K
Ehrich Elliot
15 Mar 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
4,100
$56.29
$230.79K
FRATES JAMES M
7 Mar 2017
SVP, Alks Inc; CFO ALKS
Sold after exercise
400
$59.57
$23.83K
FRATES JAMES M
7 Mar 2017
SVP, Alks Inc; CFO ALKS
Sold after exercise
24,600
$59.07
$1.45M
Cooke Shane
2 Mar 2017
President, Alkermes plc
Sold after exercise
20,000
$60.00
$1.20M
MITCHELL PAUL J
1 Mar 2017
Director
Sold after exercise
1,500
$57.06
$85.59K
Ehrich Elliot
16 Feb 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
6,085
$56.84
$345.85K
Ehrich Elliot
16 Feb 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
3,915
$56.05
$219.42K
MITCHELL PAUL J
1 Feb 2017
Director
Sold after exercise
1,500
$54.45
$81.68K
Ehrich Elliot
17 Jan 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
11,983
$54.32
$650.95K
Stejbach Mark
9 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold after exercise
547
$60.27
$32.97K
Cooke Shane
9 Jan 2017
President, Alkermes plc
Sold after exercise
550
$60.27
$33.15K
Ehrich Elliot
6 Jan 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
2,100
$60.12
$126.25K
Cooke Shane
6 Jan 2017
President, Alkermes plc
Sold after exercise
6,607
$60.07
$396.91K
Stejbach Mark
6 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold after exercise
6,653
$60.07
$399.64K
Ehrich Elliot
5 Jan 2017
EVP, R&D & CMO, Alkermes, Inc.
Sold after exercise
400
$60.08
$24.03K
Cooke Shane
5 Jan 2017
President, Alkermes plc
Sold after exercise
300
$60.10
$18.03K
Stejbach Mark
5 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold after exercise
300
$60.09
$18.03K
Showing 250 of 295 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 661
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 25
Sales straight out of an exercise 224
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 9,518,003
Sales filed before the plan box existed 12
History held since 7 Sep 2016